The Journal of pediatrics
-
The Journal of pediatrics · Jun 2014
Comparative StudyIn-hospital formula use increases early breastfeeding cessation among first-time mothers intending to exclusively breastfeed.
To evaluate in-hospital formula supplementation among first-time mothers who intended to exclusively breastfeed and determined if in-hospital formula supplementation shortens breastfeeding duration after adjusting for breastfeeding intention. ⋯ Among women intending to exclusively breastfeed, in-hospital formula supplementation was associated with a nearly 2-fold greater risk of not fully breastfeeding days 30-60 and a nearly 3-fold risk of breastfeeding cessation by day 60, even after adjusting for strength of breastfeeding intentions. Strategies should be sought to avoid unnecessary in-hospital formula supplementation and to support breastfeeding when in-hospital formula supplementation is unavoidable.
-
The Journal of pediatrics · Jun 2014
Traffic-related air pollution and asthma hospital readmission in children: a longitudinal cohort study.
To examine the association between exposure to traffic-related air pollution (TRAP) and hospital readmission for asthma or bronchodilator-responsive wheezing. ⋯ TRAP exposure is associated with increased odds of hospital readmission in white children, but not in African American children.
-
The Journal of pediatrics · Jun 2014
Comparative StudySurfactant deficiency in infants with severe acute viral bronchiolitis.
To evaluate surfactant content and function through the lamellar body count (LBC) and stable microbubble test (SMT) in mechanically ventilated infants with severe acute viral bronchiolitis. ⋯ Infants with acute viral bronchiolitis have reduced surfactant content and function. We speculate that these simple tests may be useful to identify infants with bronchiolitis who would benefit from surfactant replacement therapy.
-
The Journal of pediatrics · Jun 2014
Randomized Controlled Trial Comparative StudyAntibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
To evaluate the tolerability and immunogenicity of a booster dose of the quadrivalent meningococcal conjugate vaccine MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics, Siena, Italy) administered 3 years after primary vaccination of adolescents enrolled in a phase 3 study with either MenACWY-CRM or MenACWY-D (Menactra, Sanofi Pasteur, Swiftwater, Pennsylvania). ⋯ MenACWY-CRM can be used to boost adolescents who have received a primary vaccination with either MenACWY-CRM or MenACWY-D.